Search results
Results From The WOW.Com Content Network
Mayo v. Prometheus, 566 U.S. 66 (2012), was a case decided by the Supreme Court of the United States that unanimously held that claims directed to a method of giving a drug to a patient, measuring metabolites of that drug, and with a known threshold for efficacy in mind, deciding whether to increase or decrease the dosage of the drug, were not patent-eligible subject matter.
(March 25, 2025) Esteras v. United States: 23-7483: Whether, even though Congress excluded from list of factors to consider when revoking supervised release, a district court may rely on the Section 3553(a)(2)(A) factors when revoking supervised release. October 21, 2024 (February 25, 2025) FCC v.
He also argued a number of cases in state courts and three times before the Supreme Court of the United States. [4] His views are sometimes considered conservative, though he was a self-described Democrat. [5] [6] Monaghan was named a fellow of the American Academy of Arts and Sciences in 1988. [7] Monaghan died on January 1, 2025, at the age ...
The appeal court reversed the ruling deciding that isolated DNA had a "markedly different chemical structure" from other human genetic material. On June 13, 2013, in Association for Molecular Pathology v. Myriad Genetics the US Supreme Court partly reversed the decision again deciding, that isolated DNA even after removal of introns was not ...
The Supreme Court rules against the "independent state legislature theory," which could have stripped state courts of power to review election laws.
The Montana Supreme Court is considering a challenge to a 2023 ruling that found the state had violated its constitutional environmental protections by failing to consider the climate crisis in ...
NEW YORK (Reuters) -Ismael "El Mayo" Zambada, the notorious alleged co-founder of the Sinaloa Cartel, pleaded not guilty to U.S. drug charges on Friday after he and a son of a Mexican drug lord ...
The Supreme Court of the United States has so far handed down five per curiam opinions during its 2024 term, which began October 7, 2024, and will conclude October 5, 2025. [1] Because per curiam decisions are issued from the Court as an institution, these opinions all lack the attribution of authorship or joining votes to specific justices ...